Skip to content

Clinical trials

Phase 2 Infections trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Infections Phase: Phase 2 Country / region: United States Clear all

94 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20033
20044
20052
20063
20073
20087
20095
20105
20117
20125
20135
20146
20153
20163
20172
20182
20192
20202
20213
20226
20234
20242
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed62
Terminated16
Active, not recruiting5
Recruiting5
Unknown status3
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ViiV Healthcare16
GlaxoSmithKline8
University of North Carolina, Chapel Hill4
M.D. Anderson Cancer Center3
Medicago3
University of Wisconsin, Madison3
Fred Hutchinson Cancer Center2
Merck Sharp & Dohme LLC2
National Cancer Institute (NCI)2
National Institute of Allergy and Infectious Diseases (NIAID)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Infections94
Acquired Immunodeficiency Syndrome15
HIV Infections15
Virus Diseases13
Influenza, Human10
Respiratory Tract Infections9
Respiratory Tract Diseases8
RNA Virus Infections7
Diabetic Foot6
COVID-195

Trials

Showing 1 to 25 of 94. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.